w SUMMARY The presence of activated T cells as judged from the reaction with monoclonal antibodies (MoAb) against (a) a late stage T cell activation antigen (VLA-1), (b) the interleukin 2 (IL2) receptor (CD25), and (c) four different HLA class II molecules (HLA-DR, DRw52, DQ, and DP) was studied in 15 patients with active juvenile chronic arthritis (JCA), 10 patients with JCA in remission, and 11 age matched, healthy controls. In addition, the distribution of T 'helper/inducer' (CD4+), T 'suppressor/inducer' (CD4+,Leu8+), T 'suppressor/cytotoxic' (CD8+), and 'natural killer' (NK) cells (CD16+) was studied. Twenty patients and six controls were investigated for the capability to stimulate alloreactivated primed lymphocytes. The prevalence of VLA-1 positive, large cells was significantly increased to 5% (median value) in active JCA as compared with JCA in remission (2%, p<005) and controls (1%, p<005), whereas no significant difference between JCA in remission and controls was observed. Except for two patients with active JCA, less than 1% IL2 receptor bearing cells were found in patients with JCA and controls. No significant difference in the prevalence and expression of the various HLA class II antigens was observed between the groups. Similarly, no significant differences in stimulatory capability in secondary mixed lymphocyte culture (MLC) were seen. The distribution of T helper/inducer (CD4+), T suppressor/cytotoxic (CD8+), and NK cells was similar in active JCA, JCA in remission, and controls. The prevalence of T suppressor/inducer (CD4+,Leu8+) cells was higher in remission JCA (17%) than in active JCA (11%) and controls (10%). This increase, however, did not reach statistical significance. In conclusion, late stage but not early stage T cell activation antigens were increased in patients with active JCA as compared with patients with JCA in remission and controls, whereas some patients in remission had an increased prevalence of T suppressor/inducer cells.
T cell activation antigen in juvenile chronic arthritis 847
The present study was undertaken to investigate the possible presence in the blood of cells expressing early or late stage T cells activation antigens, or both, in patients with active JCA as compared with JCA in remission and controls. In addition, the distributions of HLA-DR, DRw52, DQ, and DP positive cells and of T helper/inducer, T suppressor/ cytotoxic, T suppressor/inducer, and NK cells in JCA and controls were studied.
Patients and methods

PATIENTS AND CONTROLS
The study comprised 25 patients classified as having (a) pauciarticular (10 patients), (b) polyarticular (11), or (c) systemic (four patients) JCA according to the EULAR WHO criteria.t2 The patients were randomly selected from patients attending the department of paediatrics, Rigshospitalet. All were white Caucasoids of Danish extraction. Nineteen (76%) were female and six (24%) male with a mean age of onset of disease of 8-1 years (range 3-15 years). Disease activity (active synovitis) was defined as the presence of at least two of the following symptoms: (a) joint pain, (b) joint swelling (due to synovial swelling or effusion), and (c) restriction of joint movement. Remission was defined as absence of signs of active synovitis and a normal erythrocyte sedimentation rate, i.e., below 10 mm/min. Accord 7 8 activation. MoAbs detecting early T cell activation markers included one against the IL2 receptor (CD25) and the various MoAbs directed against HLA class II antigens (HLA-DR, DRw52, DQ, and DP; Table 1 ). Additionally, MoAbs detecting the CD3 (Leu4, pan-T), the CD4 (Leu3, T-helper/ inducer subset), and the CD8 (Leu2, T suppressor/ cytotoxic subset) T cell surface molecules were used (Table 1) . Double fluorescence experiments were performed with the anti-CD4 (Leu3, phycoerythrin conjugated) and the anti-Leu8 MoAb (fluorescein isothiocyanate conjugated) (Table 1) . PBMC from patients with JCA and controls were used as stimulator source in secondary MLC experiments using HLA-DP and DR reactive primed lymphocytes as described in detail elsewhere. ' (Fig. la) , whereas only three of 10 patients in remission had more than 3% VLA-1 positive cells (Fig. la) group Table 2 The percentages of HLA-DP (64%) and DR (58%) positive large cells were significantly higher (p<001) than those of HLA-DRw52 (49%) and DQ (25%) positive cells (Table 2 ). In contrast, when the results for small cells were compared no differences between the percentages of HLA-DP (11%), DR Table 3 shows the prevalence of various T subpopulations in active JCA, JCA in remission, and controls. No significant differences in fractions of CD4+ (33%, 30%, and 28% respectively), CD8+ (25%, 23%, and 18%), CD16+ (11%, 7%, and 12%) and Leu8+ (41%, 42%, and 37%) cells were observed between the three groups (active JCA, JCA in remission, and controls respectively). Simi- larly the ratio of cells CD4+/CD8+ did not differ significantly between the groups. The prevalence of CD4+,Leu8+ cells (T suppressor/inducer) and the ratio CD4+,Leu8+/CD4+ were higher in JCA in remission (17% and 0-53) than in active JCA (11% and 0-44) and controls (10% and 0-42). None of these differences, however, was significant.
Discussion
In this study we demonstrated an increased pre- Conflicting data on the distribution of T helper/ inducer (CD4+) and T suppressor/cytotoxic (CD8+) subpopulations in JCA have been reported. [25] [26] [27] [28] No significant difference in the prevalence of CD4+ and CD8+ lymphocytes could be shown in the present study. The prevalence of the T suppressor/inducer subpopulation, however, defined as CD4+,Leu8+ cells, was insignificantly increased in JCA in remission as compared with patients with active disease. In healthy individuals the T suppressor/inducer subpopulation was originally identified as the subpopulation of CD4+ T cells that reacted with autoantibodies found in sera of patients with JCA.29 3"t Recently, the T suppressor/inducer subset has also been defined as CD4+ T cells reactive with various monoclonal antibodies (Leu8,3t TQ1,32 and RH33). In contrast with our findings in JCA, very low levels of T suppressor/inducer cells (<2%) were observed in infants with autoimmune neutropenia or haemolytic anaemia as compared with age matched, healthy controls (6% v 25%), whereas the number of CD8+ cells in the patients was normal. 34 In conclusion, the analysis of peripheral blood mononuclear cells may be of importance in the evaluation of the disease activity and the underlying immunopathological mechanism in JCA as VLA-1 positive cells appear in vitro after long term stimulation.8 It may be speculated that VLA-1 positive cells in JCA represent lymphocytes chronically stimulated by ectoantigen or autoantigen. Functional in vitro studies such as lymphokine production and cytotoxicity may elucidate an immunopathogenic importance of VLA-1 positive cells in JCA. 
